Preoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.

Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder

NCT02745301 ·Status: COMPLETED

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

NCT01734798 ·Status: COMPLETED ·Phase: PHASE3

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

NCT05822934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy

NCT04610385 ·Status: UNKNOWN

Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study

NCT04194112 ·Status: COMPLETED ·Phase: NA

Complications of Transurethral Resection of the Bladder Tumour

NCT03029663 ·Status: COMPLETED

S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium

NCT00045630 ·Status: COMPLETED ·Phase: PHASE2

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

NCT06287541 ·Status: RECRUITING ·Phase: NA

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504 ·Status: RECRUITING

Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins

NCT05969964 ·Status: RECRUITING

Nordic Cystectomy Study II - Albumin

NCT04523038 ·Status: UNKNOWN

Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident

NCT03148158 ·Status: UNKNOWN

Longitudinal Bladder Cancer Study for Tumour Recurrence

NCT05080998 ·Status: RECRUITING

Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT

NCT04839029 ·Status: UNKNOWN ·Phase: NA

Prophylactic Antibiotics in Cystectomy With Diversion

NCT06190197 ·Status: RECRUITING ·Phase: EARLY_PHASE1

The Role of mRNA-based Urine Test (Xpert Bladder Cancer Monitor) in Predicting the Need for Second Look Biopsy After Transurethral Resection of Non Muscle-invasive Bladder Tumor.

NCT04603612 ·Status: COMPLETED ·Phase: NA

Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade

NCT02992990 ·Status: UNKNOWN ·Phase: NA

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

NCT05084586 ·Status: UNKNOWN ·Phase: NA

Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder Cancer

NCT04245618 ·Status: UNKNOWN

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

NCT05137262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization

NCT04310813 ·Status: COMPLETED

Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder

NCT05077852 ·Status: UNKNOWN

Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery

NCT02944357 ·Status: WITHDRAWN ·Phase: NA

Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

NCT04579133 ·Status: TERMINATED ·Phase: PHASE2